Last update : 09/05/2017 | Version : 2 | ID : 138
General | |
Identification | |
Detailed name | Persistence of evidence-based medical therapies over time in patients monitored by cardiologists after a first recent ACS |
Sign or acronym | PREVENIR 4 |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL N°833542 version 8 |
General Aspects | |
Medical area |
Cardiology |
Health determinants |
Medicine |
Keywords | secondary prevention, persistence, care |
Scientific investigator(s) (Contact) | |
Name of the director | Amelineau |
Surname | Élisabeth |
Address | 3, rue J. Monier - 92500 Rueil Malmaison |
Phone | +33 (0)1 58 83 60 00 |
elisabeth.amelineau@bms.com | |
Unit | Bristol-Myers Squibb |
Name of the director | Schmidely |
Surname | Nathalie |
Address | 3, rue J. Monier - 92500 Rueil Malmaison |
Phone | +33 (0)1 58 83 60 00 |
nathalie.schmidely@bms.com | |
Unit | Bristol-Myers Squibb |
Collaborations | |
Funding | |
Funding status |
Private |
Details | Bristol-Myers Squibb France |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | Bristol-Myers Squibb France (BMS) |
Organisation status |
Private |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Not-repeated cross-sectional studies (except case control studies) |
Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. | random sampling in clusters. |
Database objective | |
Main objective | Describe the persistence of secondary prevention therapeutics, between 3 and 18 months after hospitalization for a first acute coronary syndrome (ACS), in patients monitored by private or hospital cardiologists |
Inclusion criteria | M/F >=18 years, outpatient seen in cardiology consultation, hospitalized in 2005 for a first ACS |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
Population covered |
Sick population |
Gender |
Male Woman |
Geography area |
National |
Detail of the geography area | Metropolitan France |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2006 |
Date of last collection (YYYY or MM/YYYY) | 2007 |
Size of the database | |
Size of the database (number of individuals) |
[1000-10 000[ individuals |
Details of the number of individuals | 1801 |
Data | |
Database activity |
Data collection completed |
Type of data collected |
Clinical data Biological data |
Clinical data (detail) |
Direct physical measures |
Biological data (detail) | total cholesterol, HDL, LDL, Triglycerides, glycemia |
Presence of a biobank |
No |
Health parameters studied |
Health care consumption and services |
Care consumption (detail) |
Medicines consumption |
Procedures | |
Data collection method | Paper CRF |
Participant monitoring |
No |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Link to the document | http://www.ncbi.nlm.nih.gov/pubmed/?term=PREVENIR+AND+Amelineau+E[Author] |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | Publications |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05